Multi-national biopharmaceutical company demonstrates continued confidence in Cryptzone's secure access technology
(Thomson Reuters ONE) -
Gothenburg, 3 September 2013
Cryptzone, the IT security and threat mitigation specialist, today confirmed a
renewal support and maintenance contract for AppGate appliances and software,
valued at £31k, from a multi-national biopharmaceutical company.
The renewal contract for the US and Europe is part of a broader global deal, in
which Cryptzone supports nearly 1,000 global users. Cryptzone AppGate secure
access technology from Cryptzone is used for network segmentation and remote
access to corporate based applications, such as email.
Einar Lindquist, CEO at Cryptzone, states: "It is particularly gratifying when
our long-term clients continue to place their trust in our IT security products
and services."
For more information:
Einar Lindquist, CEO, Cryptzone Group AB
einar.lindquist(at)cryptzone.com
Tel: +46 704-299 839
Beverley Stonehouse, Head of Marketing & Communications, Cryptzone Group AB
pr(at)cryptzone.com
Tel: +44 1252 419990
About the Cryptzone Group:
The Cryptzone Group is a technology innovator of proactive controls to mitigate
IT security risk. Our solutions enable organizations to securely connect,
collaborate and comply within the digital workplace, thereby improving document
security, access control and compliance auditing capabilities.
Headquartered in Sweden, the company has a presence in the USA, UK, Belgium,
Germany and Poland, as well as an extensive partner network with more than 150
global partners. For more information about the company and its solutions, visit
www.cryptzone.com.
Cryptzone's share is listed on First North, Sweden, the Nordic alternative
market operated by NASDAQ OMX. Certified Adviser is Thenberg & Kinde
Fondkommission AB.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryptzone via Thomson Reuters ONE
[HUG#1726820]
Unternehmensinformation / Kurzprofil:
Datum: 03.09.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 292981
Anzahl Zeichen: 2467
contact information:
Town:
Göteborg
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Multi-national biopharmaceutical company demonstrates continued confidence in Cryptzone's secure access technology"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryptzone (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
